Periprocedural dabigatran use is associated with higher major bleeding rate than warfarin, study finds
April 20, 2012
Patients using periprocedural dabigatran had a significantly higher major bleeding rate than those using warfarin, according to a study published online first February 1, 2012, in the Journal of the American College of Cardiology.